These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26001553)

  • 21. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance.
    Greeson NM; Mixon W; Allan WC
    Int J Pharm Compd; 2020; 24(5):371-379. PubMed ID: 32886634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 26. Incorporation of hands-on sterile technique instruction in an introductory pharmacy practice experience.
    Cretton-Scott E; Cruthirds D; Coward L
    Am J Pharm Educ; 2015 Mar; 79(2):28. PubMed ID: 25861109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.
    Goldberg RA; Flynn HW; Miller D; Gonzalez S; Isom RF
    Ophthalmology; 2013 Jul; 120(7):1448-53. PubMed ID: 23453511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy.
    Civen R; Vugia DJ; Alexander R; Brunner W; Taylor S; Parris N; Wasserman R; Abbott S; Werner SB; Rosenberg J
    Clin Infect Dis; 2006 Oct; 43(7):831-7. PubMed ID: 16941362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing benchmark rates of microbial and bacterial endotoxin contamination for radiopharmaceuticals compounded in commercial nuclear pharmacy settings.
    Weatherman KD; Augustine S; Christoff J; Galbraith W
    Int J Pharm Compd; 2013; 17(2):168-74. PubMed ID: 23696179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
    Kastango ES;
    Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a gravimetric-based technology-assisted workflow system on hazardous sterile product preparation.
    Roberts PA; Willoughby IR; Barnes N; Eckel SF; Paruscio A; Valgus JM; Amerine LB
    Am J Health Syst Pharm; 2018 Sep; 75(17):1286-1292. PubMed ID: 30139736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the Quality of Compounded Sterile Drug Products: A Historical Perspective.
    Cantrell SA
    Ther Innov Regul Sci; 2016 May; 50(3):266-269. PubMed ID: 30227062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding.
    Martin M
    Int J Pharm Compd; 2019; 23(1):47-49. PubMed ID: 30668535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basics of compounding: repackaging, part 2.
    Allen LV
    Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
    Trissel LA; Gentempo JA; Anderson RW; Lajeunesse JD
    Am J Health Syst Pharm; 2005 Feb; 62(3):285-8. PubMed ID: 15719586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A compounding compliance team at an academic medical center.
    Chaffee BW; Tharp JC; Clark JS; Kent S
    Am J Health Syst Pharm; 2020 May; 77(11):882-891. PubMed ID: 32318700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for waterborne disease outbreaks associated with drinking water---United States, 2007--2008.
    Brunkard JM; Ailes E; Roberts VA; Hill V; Hilborn ED; Craun GF; Rajasingham A; Kahler A; Garrison L; Hicks L; Carpenter J; Wade TJ; Beach MJ; Yoder Msw JS;
    MMWR Surveill Summ; 2011 Sep; 60(12):38-68. PubMed ID: 21937977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality Control-Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding.
    Allen LV
    Int J Pharm Compd; 2018; 22(3):206-217. PubMed ID: 29878889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.